Old Web
English
Sign In
Acemap
>
authorDetail
>
Lynn Harrington
Lynn Harrington
Duke University
Immunogenicity
Medicine
Adverse effect
Immunology
Placebo
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
2019
Vaccine
Christopher W. Woods
Ana M. Sanchez
Geeta K. Swamy
Micah T. McClain
Lynn Harrington
D. Freeman
Elizabeth A. Poore
Dawn K. Slifka
Danae E. Poer DeRaad
Ian J. Amanna
Mark K. Slifka
Shu Cai
Venus Shahamatdar
Michael R. Wierzbicki
Cyrille Amegashie
Emmanuel B. Walter
Show All
Source
Cite
Save
Citations (13)
Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule
2018
Journal of the Pediatric Infectious Diseases Society
Ezzeldin Saleh
Brian Eichner
Douglas W Clark
Martha E Gagliano
James M Troutman
Lynn Harrington
Monica M. McNeal
Dennis A. Clements
Show All
Source
Cite
Save
Citations (4)
Infants' Exposure to Organophosphate Esters (OPES)
2018
Kate Hoffman
Amelia Lorenzo
Joyce Grandee
Liz Schmidt
Stephanie Smith
Lynn Harrington
Jennifer Michael
Brian Eichner
Heather M. Stapleton
Show All
Source
Cite
Save
Citations (1)
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children
2017
Vaccine
Emmanuel B. Walter
Christoph P. Hornik
Lisa A. Grohskopf
Charles E. McGee
Christopher A. Todd
Oidda I. Museru
Lynn Harrington
Karen R. Broder
Show All
Source
Cite
Save
Citations (3)
1